Search results for: Alzheimer's
Filter search results
News
Newly Published Analysis: Dementia: the R&D Landscape
16 November 2015
…elsewhere*. Key observations from the literature include: R&D costs are higher for neurology and Alzheimer’s disease (AD) (as well as respiratory and oncology) than other therapy areas Higher costs are…
News
OHE Study on Pharmaceutical R&D Costs Released
3 December 2012
…600% from the 1970s[3] to the 2000s[4]. Second, success rates for clinical development are falling as tougher therapeutic areas are tackled—e.g. neurology (Alzheimer’s), autoimmune diseases (arthritis), and oncology. Success rates…
News
Meeting the Challenges of Drug Development in 2022: Summary of OHE’s 50th Anniversary Conference
11 October 2012
…great unmet medical need today are very difficult to understand and to treat; for example, cancers, autoimmune diseases and neurological diseases such as Alzheimer’s. The speakers and panellists generally agreed…